This website uses cookies to ensure you get the best experience on our website! 

Alright More information

BRODE Capital acquires AnLab

BRODE Capital acquires AnLab – an independent provider of laboratory diagnostic services

 

PRAGUE, November 26, 2014 - The investment portfolio of Luxembourg based investment fund BRODE Capital (BC) was successfully enlarged by an acquisition of a company AnLab s.r.o. (ANL) which is an independent animal health monitoring laboratory in the Central and Eastern Europe.

 

ANL is the only independent laboratory of its kind in the Central and Eastern Europe which meets the highest international regulatory standards in the areas of serology, bacteriology, parasitology and pathology. ANL is also focused on delivery of laboratory animals/ research models. Through years in business it has developed wide international network of clients and suppliers mainly from developed EU countries and Switzerland.

Josef Trnka, Chairman of the Board of Directors, BRODE Capital said, “the laboratory animal industry as a whole has positive outlook with increasing focus on health monitoring of laboratory animals mostly due to the increased demand for such services which is driven by intensified research & development activities among biotech and med-tech as well as traditional pharmaceutical companies.“

 

BRODE CAPITAL S.C.A., SICAV-SIF is an investment company incorporated in the Grand Duchy of Luxembourg in November 2013. BC main focus is on investment and strategic development of a wide portfolio of companies in healthcare and pharmaceutical sectors such as pharmacies, clinical centers, distribution and trade with medical products or healthcare devices, health insurance, research related to healthcare, healthcare and services projects oriented on seniors and population ageing. The geographical focus of the investment selection process is oriented on EU countries with transparent regulatory and legal environments.

www.brode.eu

 

Documents to download

  Return to Press releases